STRATA CRITICAL MEDICAL, INC. Selling, General and Administrative Expense
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Selling, General and Administrative Expense of $14.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $14.00M, a 5.30% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $15.61M, a 26.56% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. selling, general and administrative expense for the quarter ending 2025-06-30 was $13.29M.
- STRATA CRITICAL MEDICAL, INC. selling, general and administrative expense for the quarter ending 2025-03-31 was $12.33M.
- STRATA CRITICAL MEDICAL, INC. selling, general and administrative expense for fiscal 2025 was $60.88M, a 19.70% increase from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. selling, general and administrative expense for fiscal 2024 was $50.86M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.00M 10-Q · filed 2026-08-04 | $29.60M 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | $15.61M 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $60.88M 10-K · filed 2026-03-03 | |||
| 2025-06-30 | $13.29M 10-Q · filed 2026-08-04 | $25.62M 10-Q · filed 2026-08-04 | ||
| 2025-03-31 | $12.33M 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | $50.86M 10-K · filed 2026-03-03 | |||
| 2021-06-30 | $790.00K 10-Q · filed 2021-08-16 | $2.09M 10-Q · filed 2021-08-16 | ||
| 2020-06-30 | $329.00K 10-Q · filed 2021-08-16 | $2.28M 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |